Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr HIV/AIDS Rep. 2012 Sep;9(3):251-8. doi: 10.1007/s11904-012-0126-8.

When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!

Author information

1
Stanford University, Stanford, CA, USA. pmgrant@stanford.edu

Abstract

Despite the substantial benefits of combination antiretroviral therapy (ART), a significant proportion of HIV-infected individuals still present with advanced disease and active AIDS-related opportunistic infections (OIs). The weight of evidence from recent studies supports the early initiation of ART (ie, within 2 weeks of initiating treatment for the acute OIs). Initiating ART early in acutely ill patients can reduce AIDS-related progression and death. Early ART has not been associated with increased rates of immune reconstitution inflammatory syndrome in prospective studies of non-tuberculosis OIs, although this concern is frequently cited as a reason to delay ART. Nor has early ART been associated with increased adverse outcomes. Nonetheless, initiating ART early in acute care settings can be challenging to implement and requires a well-coordinated multidisciplinary team with expertise in ART management.

PMID:
22733609
DOI:
10.1007/s11904-012-0126-8
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center